Advancing Fungal Synthetic Biology for Industrial Excellence. Aspergillus niger stands as a paramount multicellular host in the biotechnology industry, prized for its robust secretion system and versatile metabolic capabilities. However, its complex genomic landscape and multinucleated nature necessitate high-precision tools for effective modification. CD Biosynsis provides professional Aspergillus niger Genome Editing Services, offering a comprehensive suite of advanced genetic engineering solutions. Leveraging the latest CRISPR-Cas9 technologies, we enable seamless gene knockouts, precise knock-ins, and sophisticated point mutations to transform Aspergillus niger into a highly efficient and stable cell factory.
Get a Technical QuoteOur genome editing platform integrates cutting-edge molecular tools to provide "scarless" and marker-free modifications, ensuring the development of superior industrial strains tailored for organic acids, enzymes, and high-value metabolites.
| Service Tier | Technical Focus | Primary Application | Industrial Value |
|---|---|---|---|
| CRISPR-Cas9 Editing | RNP or Vector-based DSBs | Precise genomic rewiring | High-efficiency site-specific modification |
| Gene Knockout | Permanent gene disruption | Byproduct elimination | Streamlines metabolic flux & purity |
| Gene Knock-in | Site-specific integration | Multi-copy protein expression | Ensures genetic stability & high titers |
| CRISPRi Repression | dCas9 transcriptional blocking | Essential gene study | Reversible & tunable metabolic tuning |
| Base Editing | Single nucleotide conversion | Enzyme active site refinement | Surgical precision without DNA breaks |
1. Genomic Mapping
2. Editing System Design
3. Transformation
4. Performance Validation
Bioinformatic analysis to select optimal gRNA targets and integration sites within the Aspergillus niger genome for maximum efficiency.
Technical project feasibility study and Mutual NDA signing.
Selection of the appropriate modality (CRISPR-Cas9, CRISPRi, or Base Editing) based on the desired industrial phenotype.
Optimization of nuclease activity and donor template architecture.
Delivery of editing machinery via optimized protoplast-mediated transformation or RNP (Ribonucleoprotein) delivery for transient activity.
Strict aseptic processing to maintain industrial strain integrity.
High-throughput screening followed by NGS verification and fermentation trials to evaluate titer, yield, and genetic stability.
Final delivery of engineered strains and comprehensive characterization dossiers.
We benchmark our precision engineering against landmark research to deliver world-class industrial strains.
Maximizing the expression of enzymes like amylase is core to fermentation optimization. Technical benchmarks successfully utilized a CRISPR/Cas9-based multi-copy integration system (MCT) to target specific loci for high-efficiency recombination. By bypassing random insertion limits, this platform significantly enhanced target protein expression, ensuring stable and predictable industrial enzyme production.
(Reference: The FEBS Journal, 2023)
The safety of strains used in food-grade organic acid production is paramount. In citric acid hyper-producing strains, CRISPR/Cas9 has been deployed to knock out key genes associated with mycotoxin biosynthesis. Coupled with NGS and metabolite analysis, these projects confirmed that edited strains do not produce carcinogenic mycotoxins, ensuring the biosafety of fungal factories.
(Reference: Mycoscience, 2022)
Optimizing sugar substrate utilization requires deep metabolic insight. Research focused on using CRISPR/Cas9 for targeted knockouts and point mutations of the amylolytic regulator AmyR. By precisely editing this transcription factor, researchers elucidated its role in sucrose utilization, allowing for the reconstruction of metabolic pathways to improve carbon source efficiency.
(Reference: Journal of Fungi, 2023)
Ready to transform your Aspergillus niger strains into high-performance cell factories?
Contact Us1. Is CRISPR-Cas9 effective in specialized industrial Aspergillus strains?
Yes. Our platform is specifically optimized for industrial-grade Aspergillus niger backgrounds, including those with highly specialized metabolic profiles used in organic acid production.
2. Can you perform multiple genomic edits in a single transformation?
Absolutely. We offer multiplexing services where multiple genes or entire pathways can be targeted simultaneously using a single CRISPR-Cas9 construct or RNP pool.
3. How do you handle the multinucleated nature of the fungus?
We utilize specialized protoplast isolation and single-spore purification protocols to ensure all nuclei carry the intended genetic modification, resulting in a stable, homokaryotic strain.
4. What is the typical turnaround time for a custom genome editing project?
A typical project, from initial design to a validated, purified strain, takes approximately 10 to 14 weeks, depending on the complexity of the genetic modification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.